Trial · NCT01134055
Adverse events812
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 812
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Placebo Control Arm QID | 11 | 73 | |
| other | Nasopharyngitis | Infections and infestations | Pazopanib Eye Drops 5 mg/mL TID | 5 | 72 | |
| other | Nasopharyngitis | Infections and infestations | Pazopanib Eye Drops 5 mg/mL QID | 6 | 74 | |
| other | Nasopharyngitis | Infections and infestations | Pazopanib Eye Drops 10 mg/mL BID | 17 | 73 | |
| other | Nasopharyngitis | Infections and infestations | Pazopanib Eye Drops 10 mg/mL TID | 5 | 73 | |
| other | Nasopharyngitis | Infections and infestations | Pazopanib Eye Drops 10 mg/mL QID | 13 | 72 | |
| other | Nasopharyngitis | Infections and infestations | Ranibizumab Injections Active Open-label Control Arm | 5 | 73 | |
| other | Hypertension | Vascular disorders | Placebo Control Arm QID | 3 | 73 | |
| other | Hypertension | Vascular disorders | Pazopanib Eye Drops 5 mg/mL TID | 4 | 72 | |
| other | Hypertension | Vascular disorders | Pazopanib Eye Drops 5 mg/mL QID | 5 | 74 | |
| other | Hypertension | Vascular disorders | Pazopanib Eye Drops 10 mg/mL BID | 4 | 73 | |
| other | Hypertension | Vascular disorders | Pazopanib Eye Drops 10 mg/mL TID | 6 | 73 | |
| other | Hypertension | Vascular disorders | Pazopanib Eye Drops 10 mg/mL QID | 6 | 72 | |
| other | Hypertension | Vascular disorders | Ranibizumab Injections Active Open-label Control Arm | 7 | 73 | |
| other | Urinary tract infection | Infections and infestations | Placebo Control Arm QID | 9 | 73 | |
| other | Urinary tract infection | Infections and infestations | Pazopanib Eye Drops 5 mg/mL TID | 3 | 72 | |
| other | Urinary tract infection | Infections and infestations | Pazopanib Eye Drops 5 mg/mL QID | 1 | 74 | |
| other | Urinary tract infection | Infections and infestations | Pazopanib Eye Drops 10 mg/mL BID | 6 | 73 | |
| other | Urinary tract infection | Infections and infestations | Pazopanib Eye Drops 10 mg/mL TID | 6 | 73 | |
| other | Urinary tract infection | Infections and infestations | Pazopanib Eye Drops 10 mg/mL QID | 4 | 72 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01134055/events